How big is the Rare Disease Genetic Testing Market?

The Rare Disease Genetic Testing Market size is expected to reach USD 1.06 billion in 2024 and grow at a CAGR of 14.23% to reach USD 2.06 billion by 2029. Read More

What is the current Rare Disease Genetic Testing Market size?

In 2024, the Rare Disease Genetic Testing Market size is expected to reach USD 1.06 billion. Read More

Who are the key players in Rare Disease Genetic Testing Market?

Quest Diagnostics Incorporated, Invitae Corporation, 3billion Inc., Eurofins Scientific, Inc. and Centogene N.V. are the major companies operating in the Rare Disease Genetic Testing Market. Read More

Which is the fastest growing region in Rare Disease Genetic Testing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Rare Disease Genetic Testing Market?

In 2024, the North America accounts for the largest market share in Rare Disease Genetic Testing Market. Read More

What years does this Rare Disease Genetic Testing Market cover, and what was the market size in 2023?

In 2023, the Rare Disease Genetic Testing Market size was estimated at USD 0.93 billion. The report covers the Rare Disease Genetic Testing Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Rare Disease Genetic Testing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Rare Disease Genetic Testing Market

Rare Disease Genetic Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Rare Disease Genetic Testing Market is Segmented by Technology (Next-generation Sequencing, Array Technology, PCR-based Testing, FISH, and Other Technologies), Disease (Neurological Disorders, Immunological Disorders, Hematology Diseases, Endocrine and Metabolism Diseases, Cancer, Musculoskeletal Disorders, and Other Diseases), End User (Clinics/Hospitals, Diagnostic Laboratories, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Rare Disease Genetic Testing Industry Overview

The rare disease genetic testing market is highly competitive and fragmented due to the presence of many players. These players are present globally and regionally, which include Quest Diagnostics Incorporated, Eurofins Scientific Inc., SAmbry Genetics Corporations, PerkinElmer Genetics Inc., Baylor Miraca Genetics Laboratories LLC, and Beijing Genomics Institute Ltd.